TrialMedical mycology2024

Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598.

Kenan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.